NuChem Sciences a CRO specialized in preclinical drug discovery, offering standalone & integrated services. We Transform Ideas Through Science. Since August 2023, NuChem Sciences is now a Sygnature Discovery business.
| Website | http://www.nuchemsciences.com |
| Revenue | $43.3 million |
| Employees | 193 (15 on RocketReach) |
| Founded | 2011 |
| Address | 2350 Rue Cohen, Suite 201, Montreal, Quebec H4R 2N6, CA |
| Phone | +1 514-416-5659 |
| Industry | Research Services |
| Keywords | Cro Services, Drug Development, Pharmaceutical Research, Biopharmaceutical Services, Integrated Services, Preclinical Research, Drug Discovery Services, Clinical Research Organization, Pharmaceutical Development, Life Sciences, Drug Research, Scientific Research, Research Services, Contract Research, Pharmaceutical Cro, Biotechnology, Discovery Research, Lead Optimization |
| Competitors | Charles River Laboratories, Syngene International Limited, Evotec, Eurofins, WuXi AppTec, Research Pharmaceutical Services, Clinipace Worldwide, Medpace, inVentiv Health Commercial, Catalent Pharma Solutions +39 more (view full list) |
Looking for a particular NuChem Sciences employee's phone or email?
The NuChem Sciences annual revenue was $43.3 million in 2026.
Malken Bayrakdarian is the Vice President, Drug Discovery of NuChem Sciences.
15 people are employed at NuChem Sciences.
NuChem Sciences is based in Montreal, Quebec.